The support of R&D projects by experts and specialized firms can be essential in the development of a drug. This enables informed choices to be made more quickly, which is necessary for emergency situations such as those generated by the COVID-19 epidemic.
This service is designed for Biotech companies developing SARS-CoV-2 new drugs.
Materials to provide
- Details about the project
Further details on the project may be requested.
You will be able to exchange directly with the experts after filling in the form below.
- Consulting service as validated with the Expert